Kenji Hashimoto
Professor, Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health
Data updated
Research Footprint
Kenji Hashimoto appears in 7 tracked papers (2014–2022), most studied alongside Ketamine, Esketamine and Placebo, across Major Depressive Disorder (MDD), Depressive Disorders and Suicidality.
Most-cited paper: R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects (597 citations).
Frequent co-authors: Gerard Sanacora, Colleen Loo and Acioly Luiz Tavares Lacerda.
Background & Research
Kenji Hashimoto is a professor at Chiba University’s Center for Forensic Mental Health, where he leads research in clinical neuroscience, biological psychiatry, and neuropsychopharmacology. His work has focused heavily on ketamine and its enantiomer arketamine, including preclinical and clinical studies on rapid antidepressant effects and predictive biomarkers. He has published extensively in the field and is widely cited in ketamine/psychedelic-adjacent psychiatric research.
Key Impact
He is a leading Japanese psychiatric researcher whose work on ketamine, arketamine, and related biomarkers has helped shape modern rapid-acting antidepressant research.
Collaboration Network
4 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Kenji Hashimoto is associated with.